MedPath

comparison of dexmedetomidine and propofol sedation in IC

Phase 3
Conditions
Sedation in ICU patients.
Registration Number
IRCT20230828059291N1
Lead Sponsor
Babol University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
70
Inclusion Criteria

patients over 18 years old
staying in ICU for at least 24 hours after surgery
need to be intubated and be sedated

Exclusion Criteria

Hypotension (SBP<90)
pregnant women
obesity (body weight more than 50% higher than ideal body weight)
ESRD patients
Glasgow Coma Scale (GCS) below 12 (moderate and severe brain damage)
Significant arrhythmia or high degree of atrioventricular node block
patients who are allergic to the drugs

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Comparison of the need for narcotic drug (fentanyl) in dexmedetomidine and propofol groups. Timepoint: The amount of injected fentanyl will be measured at the end of 24 hours. Method of measurement: The amount of fentanyl injection will be recorded during the study.
Secondary Outcome Measures
NameTimeMethod
Respiratory parameters (respiratory rate, spontaneous breathing and airway pressure). Timepoint: Respiratory parameters will be recorded at intervals of 30 minutes, 1 hour, 3 hours, 6 hours, 12 hours and 24 hours. Method of measurement: The mentioned variables are measured by ventilator devices and then recorded at the time intervals.;Level of consciousness. Timepoint: The level of consciousness will be recorded at intervals of 30 minutes, 1 hour, 3 hours, 6 hours, 12 hours and 24 hours. Method of measurement: The level of consciousness will be measured by Ramsay Sedation Scale.;Hemodynamic parameters (systolic and diastolic blood pressure, heart rate, mean arterial blood pressure). Timepoint: Hemodynamic parameters will be recorded at intervals of 30 minutes, 1 hour, 3 hours, 6 hours, 12 hours and 24 hours. Method of measurement: The monitoring device.
© Copyright 2025. All Rights Reserved by MedPath